7.1 Prescription Transfer Rules & Audit Trails

Key Takeaways

  • Under N.J.A.C. 13:39-7.8 and 21 CFR § 1306.25, prescription transfers must occur directly between two licensed pharmacists or registered pharmacy interns/externs; registered pharmacy technicians and pharmacy clerks are strictly prohibited from transferring or receiving transfers.
  • In New Jersey, all original prescription and transfer records—including VOID notations and incoming transfer audit trails—must be retained for a mandatory minimum of 5 years (N.J.A.C. 13:39-7.6), superseding the federal 2-year CSA requirement.
  • Schedule III, IV, and V controlled dangerous substances (CDS) may only be transferred on a ONE-TIME basis between pharmacies that do not share a common database, but may be transferred up to the maximum prescriber-authorized refills (up to 5 refills within 6 months) if pharmacies share a real-time, online electronic database.
  • Schedule II controlled substances issued on paper or received verbally can NEVER be transferred under any circumstances; however, under the 2023 DEA EPCS transfer rule, an unfilled electronic Schedule II-V prescription may be transferred electronically between DEA-registered pharmacies.
  • The transferring pharmacist must invalidate the prescription by recording 'VOID' on the face and documenting the receiving pharmacy's name, address, receiving pharmacist's name, transfer date, and transferring pharmacist's initials; the receiving pharmacist must write 'TRANSFER' and document 9 mandatory statutory audit trail elements.
Last updated: September 2026

7.1 Prescription Transfer Rules & Audit Trails

[!NOTE] Core Regulatory Authorities: Prescription transfer protocols in New Jersey are governed by the New Jersey State Board of Pharmacy rules at N.J.A.C. 13:39-7.8, New Jersey Controlled Dangerous Substances regulations at N.J.A.C. 13:45H, federal Drug Enforcement Administration (DEA) rules at 21 CFR § 1306.25, and the DEA Final Rule on the Transfer of Electronic Prescriptions for Schedules II-V Controlled Substances (88 FR 48365).

The transfer of prescription information between retail pharmacies is a critical professional workflow designed to ensure continuity of care while preventing diversion, duplicate dispensing, and unauthorized refill accumulation. Because pharmacy jurisprudence intersects both state administrative mandates and federal Drug Enforcement Administration (DEA) standards, candidates preparing for the New Jersey MPJE must master the strict procedural boundaries governing who may communicate transfers, what information must be captured in the audit trail, how controlled substances differ from non-controlled drugs, and the exact duration records must be preserved.


Authorized Personnel: The Direct Communication Standard

Under N.J.A.C. 13:39-7.8(a), the transfer of prescription information for the purpose of refill dispensing is permissible only when communicated directly between authorized healthcare professionals.

+---------------------------------------------------------------------------------------------------+
|                         AUTHORIZED PERSONNEL FOR PRESCRIPTION TRANSFERS                           |
+---------------------------------------------------------------------------------------------------+
| PERMITTED IN NEW JERSEY:                                                                          |
|   ├── Licensed Pharmacists (RPh)                                                                 |
|   └── Registered Pharmacy Interns / Externs (under the direct supervision of a licensed RPh)     |
+---------------------------------------------------------------------------------------------------+
| STRICTLY PROHIBITED IN NEW JERSEY:                                                                |
|   ├── Registered Pharmacy Technicians (technicians CANNOT send or receive transfers)              |
|   ├── Pharmacy Technician Trainees                                                                |
|   ├── Pharmacy Cashiers / Clerks / Support Staff                                                  |
|   └── Unlicensed Pharmacy Personnel                                                               |
+---------------------------------------------------------------------------------------------------+

[!WARNING] High-Yield MPJE Trap: Pharmacy Technicians and Transfers: In some states, certified pharmacy technicians are granted limited authority to transfer non-controlled prescriptions. In New Jersey, pharmacy technicians are strictly prohibited from transferring or receiving ANY prescription transfer, whether non-controlled or controlled. Any transfer communication involving a technician violates N.J.A.C. 13:39-7.8 and exposes both the technician and the supervising pharmacist to formal administrative disciplinary action.

Transfers may be communicated verbally via telephone, via secure facsimile (fax), or electronically through a shared computer system. However, when conducted verbally or via fax, the communication must involve two licensed individuals (pharmacist-to-pharmacist, pharmacist-to-intern, or intern-to-intern).


Duties of the Transferring Pharmacy

When a New Jersey pharmacy transfers a prescription to another dispensing facility, the transferring pharmacist (or registered intern) must immediately perform specific invalidation and record-keeping actions to terminate the legal validity of the prescription at their site.

1. Invalidation of the Original Prescription

  • Paper Prescriptions: The transferring pharmacist must write the word "VOID" clearly across the face of the original hard-copy prescription.
  • Electronic Prescriptions: In an electronic recordkeeping system, the prescription record must be electronically marked as "VOID," "INACTIVE," or "TRANSFERRED" in a manner that completely prevents any further refill dispensing at that location.

2. Required Transfer Audit Trail Entries (Transferring Side)

Under N.J.A.C. 13:39-7.8(a)(1) and federal regulations, the transferring pharmacist must record on the reverse side of the invalidated paper prescription (or enter into the computerized record) the following data points:

  1. Name and Address of the receiving pharmacy to which the prescription was transferred.
  2. DEA Registration Number of the receiving pharmacy (mandatory if transferring a Schedule III, IV, or V controlled dangerous substance).
  3. Name of the Receiving Individual: The full name of the licensed pharmacist or registered intern receiving the transfer.
  4. Date of Transfer: The exact calendar date on which the transfer took place.
  5. Identity of Transferring Individual: The initials, name, or unique electronic identifier of the transferring pharmacist or intern.

Once transferred, the original prescription becomes entirely null and void at the transferring pharmacy. The pharmacy cannot dispense any further refills unless the prescription is formally transferred back pursuant to applicable legal transfer limits.


Duties of the Receiving Pharmacy

The receiving pharmacist (or registered intern) who accepts a transferred prescription must generate a new legal record and document an exhaustive statutory audit trail. Under N.J.A.C. 13:39-7.8(a)(2), the receiving prescription is treated as an oral or electronic prescription order.

1. Designation of the Transferred Status

  • The receiving pharmacist must write the word "TRANSFER" prominently across the face of the newly created prescription order (or enter the "Transferred" status flag into the pharmacy dispensing computer system).

2. The Nine Mandatory Audit Trail Elements

The receiving pharmacist must obtain and record all of the following nine data elements prior to dispensing:

Statutory ElementDescription & Compliance Requirement
1. Original Date of IssueThe exact date the prescription was written/issued by the prescriber.
2. Original Dispensing DateThe date the original prescription was first dispensed (if previously filled).
3. Authorized RefillsThe original number of refills authorized by the prescriber.
4. Valid Refills RemainingThe number of valid, un-dispensed refills remaining on the prescription.
5. Previous Refill HistoryThe date(s) and location(s) (pharmacy name/identifier) of all previous refills.
6. Original Prescription NumberThe serial/prescription number assigned by the transferring pharmacy.
7. Transferring Pharmacy InfoThe complete legal name and street address of the transferring pharmacy.
8. Transferring Pharmacy DEA #Mandatory if the medication is a Schedule III, IV, or V controlled substance.
9. Personnel IdentifiersThe name of the transferring pharmacist/intern and the name/initials of the receiving pharmacist/intern.

[!IMPORTANT] Prescription Expiration Calculation: A transferred prescription retains its original expiration timeline calculated from the ORIGINAL DATE OF ISSUANCE, never from the date of the transfer. For non-controlled substances in New Jersey, a prescription expires 1 year from the original date of issuance. For Schedule III, IV, and V controlled substances, the prescription expires 6 months from the original date of issuance or after 5 authorized refills, whichever occurs first (21 CFR § 1306.22; N.J.A.C. 13:45H-7.14).


Controlled Substance Transfers: Schedules III, IV, and V

Prescription transfers involving Controlled Dangerous Substances (CDS) in Schedules III, IV, and V are subject to heightened federal and state restrictions under 21 CFR § 1306.25 and N.J.A.C. 13:39-7.8.

+---------------------------------------------------------------------------------------------------+
|                         CONTROLLED SUBSTANCE (C-III TO C-V) TRANSFER RULES                        |
+---------------------------------------------------------------------------------------------------+
| Scenario A: Pharmacies DO NOT Share a Real-Time Online Database (e.g., Independent to Chain)       |
|   └── MAXIMUM TRANSFERS: ONE TIME ONLY.                                                           |
|       (All remaining authorized refills must be dispensed at the receiving pharmacy).             |
+---------------------------------------------------------------------------------------------------+
| Scenario B: Pharmacies SHARE a Real-Time, Centralized Electronic Database (e.g., CVS to CVS)      |
|   └── MAXIMUM TRANSFERS: UP TO MAXIMUM AUTHORIZED REFILLS.                                        |
|       (Can transfer back and forth up to 5 refills within 6 months from issue date).              |
+---------------------------------------------------------------------------------------------------+

1. The One-Time Transfer Rule (Independent / Unlinked Pharmacies)

Under 21 CFR § 1306.25(a), the transfer of original prescription information for a Schedule III, IV, or V controlled substance for refill dispensing is permissible between retail pharmacies on a one-time basis only if the pharmacies do not share a common real-time electronic database. Once transferred, the prescription cannot be transferred to a third pharmacy or back to the original pharmacy.

2. The Real-Time Online Database Exception

Pharmacies that share a real-time, centralized online electronic database (such as intra-chain community pharmacies that utilize a unified corporate dispensing system) are exempt from the one-time transfer limitation. In a shared system, patients may transfer and refill Schedule III, IV, or V prescriptions up to the maximum number of refills permitted by law and authorized by the prescriber (maximum of 5 refills within 6 months from the date of issue). Each transfer within a shared network must generate a complete electronic audit trail verifying that refills are decremented from the shared profile in real time.

3. Electronic Prescription Transfers: The 2023 DEA Final Rule (88 FR 48365)

Historically, the DEA prohibited the transfer of an unfilled controlled substance prescription because regulations stated transfers applied only to "refill dispensing." On July 27, 2023, the DEA promulgated a landmark Final Rule (effective August 28, 2023) amending 21 CFR Part 1306:

  • Scope: Permits the transfer of an unfilled electronic prescription for a controlled substance in Schedules II, III, IV, or V between retail pharmacies for initial dispensing.
  • Technological Requirement: The transfer must be performed electronically from one EPCS-certified pharmacy system to another. It CANNOT be converted to fax, paper, or communicated verbally by telephone.
  • Audit Trail: The electronic prescription must remain in its electronic format, and the transferring and receiving systems must update their records to reflect the transfer, including date, names, and DEA registration numbers of both entities.
  • Crucial Distinction: This rule applies EXCLUSIVELY to electronic prescriptions (EPCS). An unfilled paper or oral controlled substance prescription can NEVER be transferred for an initial fill.

Schedule II Prescriptions: Strict Transfer Prohibitions

Schedule II controlled dangerous substances represent the highest level of pharmacological risk and abuse liability available via prescription. Under federal and New Jersey law:

  • No Refills Permitted: Schedule II prescriptions cannot be refilled (N.J.S.A. 24:21-15; 21 CFR § 1306.12). Because traditional transfers are legally defined as transfers for "refill dispensing," paper and oral Schedule II prescriptions CAN NEVER BE TRANSFERRED.
  • Unfilled Paper Schedule II Prescriptions: If a patient presents a written New Jersey Prescription Blank (NJPB) for a Schedule II drug (e.g., OxyContin, Adderall, Percocet) to Pharmacy A, and Pharmacy A is out of stock, Pharmacy A CANNOT transfer the prescription to Pharmacy B. The pharmacist must return the original physical NJPB to the patient, who may then carry it to Pharmacy B.
  • Unfilled Electronic Schedule II Prescriptions: Under the DEA 2023 EPCS transfer rule, if the original C-II was transmitted as an e-prescription, it may be transferred electronically between DEA-registered pharmacies if both pharmacy software vendors support certified EPCS-to-EPCS electronic transfer protocols.

Record Retention: New Jersey 5-Year Mandate

A critical area where New Jersey law is substantially more stringent than federal law is record retention:

Jurisdiction / Regulatory BodyMinimum Prescription & Transfer Record Retention Period
Federal DEA (21 CFR § 1304.04)2 Years from the date of creation or last dispensing
New Jersey Board of Pharmacy (N.J.A.C. 13:39-7.6 & 7.8)5 Years from the date of creation, transfer, or last dispensing
New Jersey Controlled Substances (N.J.A.C. 13:45H-5.4)5 Years (CDS inventory, receipt, and dispensing records)

[!CAUTION] Exam Pitfall: On the MPJE, when asked for the required retention period for prescription records, transfer logs, or controlled substance dispensing records in New Jersey, the correct answer is 5 YEARS. Never select 2 years, which is merely the federal baseline. New Jersey pharmacists must maintain all transfer records for 5 years, and these records must be immediately retrievable for inspection by Board of Pharmacy inspectors or DCA enforcement agents upon request.

Test Your Knowledge

A retail pharmacy in Cherry Hill receives a telephone call from a neighboring pharmacy requesting the transfer of a non-controlled prescription for atorvastatin 20 mg. The caller identifies themselves as a registered pharmacy technician calling on behalf of their supervising pharmacist. Under N.J.A.C. 13:39-7.8, how should the receiving pharmacist handle this request?

A
B
C
D
Test Your Knowledge

A patient presents to an independent pharmacy in New Brunswick with an original prescription for clonazepam 1 mg (Schedule IV) that was originally issued 2 months ago with 5 authorized refills. The prescription was originally filled and subsequently refilled once at an independent pharmacy in Princeton. The two pharmacies do not share a common computerized database. Under 21 CFR § 1306.25 and New Jersey law, what is the maximum number of times this prescription may be transferred between these independent pharmacies?

A
B
C
D
Test Your Knowledge

Under New Jersey State Board of Pharmacy administrative rules (N.J.A.C. 13:39-7.6 and N.J.A.C. 13:39-7.8), what is the mandatory minimum time period that a retail pharmacy must retain records of prescription transfers and invalidated 'VOID' prescription orders?

A
B
C
D
Test Your Knowledge

A patient walks into a retail pharmacy in Morristown with an unfilled physical New Jersey Prescription Blank (NJPB) for OxyContin 40 mg (Schedule II). The pharmacy is currently out of stock of the medication. The patient asks the pharmacist to transfer the written prescription over the telephone to a competing pharmacy down the street that has the drug in stock. How must the pharmacist respond under state and federal law?

A
B
C
D